Table X.
Number of Formulations with Light and Temperature Sensitivity Indication by Dosage Form
| Dosage From | Total Formulations (nā=ā557) | Protect from Light | Do Not Freeze | ||
|---|---|---|---|---|---|
| Indication | No Indication | Indication | No Indication | ||
| Solid (oral) | 11 (1.97%) | 0 (0.00%) | 11 (100.0%) | 0 (0.00%) | 11 (100.0%) |
| Lyophilized powder | 154 (27.65%) | 88 (57.14%) | 66 (42.86%) | 86 (55.84%) | 68 (44.16%) |
| Liquid | 389 (69.84%) | 371 (95.37%) | 18 (4.63%) | 363 (93.32%) | 26 (6.68%) |
| Topical | 3 (0.54%) | 0 (0.00%) | 3 (100.0%) | 1 (33.33%) | 2 (66.67%) |